期刊文献+

磷酸肌酸减少大鼠缺血再灌注心肌细胞凋亡及自噬泡的数量 被引量:6

Creatine phosphate decreases the apoptosis and autophagy in myocardial ischemia/reperfusion rat heart
暂未订购
导出
摘要 目的研究磷酸肌酸减少大鼠缺血再灌注心肌细胞凋亡及自噬的能力。方法雄性SD大鼠24只,体质量200~250 g,随机均分为假手术(sham)组、缺血/再灌注(ischemia-reperfusion,I/R)组和磷酸肌酸钠(phosphocreatine,CP)干预组。其中CP组按4 mg/kg磷酸肌酸钠剂量于再灌注前经右股静脉注射。用TUNEL法检测心肌细胞凋亡;电子显微镜观察心肌细胞自噬泡的发生和线粒体的形态学改变;Western blot检测微管相关蛋白1轻链3-Ⅱ(LC3-Ⅱ)蛋白的表达。结果 I/R组与sham组相比,线粒体超微结构损伤加重,自噬泡数量增多(P<0.01),心肌细胞凋亡率明显增加(P<0.01);CP干预组可减轻I/R组线粒体超微结构损伤,自噬泡数量减少(P<0.05),降低心肌细胞凋亡率(P<0.05);LC3-Ⅱ作为评价自噬强度的指标,I/R组与sham组相比,LC3-Ⅱ蛋白的表达明显上调(P<0.01);而CP与I/R组相比,该蛋白表达明显下调(P<0.05)。结论磷酸肌酸通过减少大鼠缺血再灌注心肌细胞凋亡及自噬泡的数量,从而减轻心肌缺血再灌注损伤。 Objective To investigate the role of Creatine phosphate in myocardial ischemia-reperfusion(I/R) inju- ry of rat heart. Methods Twenty-four male SD rats weighing 200 - 250 g, were randomly divided into a Sham group ; a I/R group and a phosphocreative (CP) group. CP group were taken the intravenous administration of 4 mg/kg creatine phosphate sodium before the reperfusion. TUNEL method was used to detect apoptosis of cardio- myocytes. The formation of autophagosomes was observed by electron microscopy. Expression of LC3-Ⅱ was meas- ured by the Western blot. Results Comparing with sham group, I/R aggravated injury of mitochondria, and in- creased autophagic vacuoles(AVs) (P 〈 0. 01 ) and apoptosis of cardiomyocytes (P 〈 0.01 ). However, CP group alleviated injury of mitochondria and reduced autophagic vacuoles( P 〈 0. 05 ) and apoptosis of cardiomyocytes( P 〈 0. 05) comparing to I/R group. LC3-Ⅱ formation, an autophagy marker, was down-regulated in the CP group (P 〈 0.01 ), which was less increased than I/R-injured rats( P 〈 0.05 ). Conclusions Creatine phosphate inhibitsapoptosis and excessive autophagy to diminish the cell death induced by the myocardial I/R injury.
出处 《基础医学与临床》 CSCD 北大核心 2013年第7期864-867,共4页 Basic and Clinical Medicine
基金 湖北省自然科学基金(2011CDB382)
关键词 自噬 缺血再灌注损伤 磷酸肌酸 凋亡 autophagy ischemia-reperfusion injury creatine phosphate apoptosis
  • 相关文献

参考文献9

  • 1Ingwall JS. Energy metabolism in heart failure and remodel- ling[J]. Cardiovasc Res, 2009, 81:all2-9.
  • 2Matsui Y, Takagi H, Qu X, et al. Distinct roles of autoph- agy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinaseand Beclin 1 in mediating au- tophagy[J]. Circ Res, 2007, 100:914-922.
  • 3Cahnettes G, Deschodt-Arsac V, Gouspillou G, et al. hn- proved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced altered cardiac energetics [ J ]. PLoS One, 2010, 5:1 -7.
  • 4Jacobus WE. Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase[J]. Annu Rev Physiol, 1985, 47:707-725.
  • 5刘薇,黄宇光.冠心病患者行非心脏手术的术前评估及处理[J].临床麻醉学杂志,2004,20(8):483-485. 被引量:29
  • 6Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis[ J]. Nat Rev Mol Cell Biol, 2007, 8:741 -752.
  • 7刘瑛琪,李天德,任艺虹,李宁.磷酸肌酸对心肌细胞线粒体的保护作用[J].心脏杂志,2004,16(1):14-16. 被引量:56
  • 8Bernards R, Weinberg RA. A progression puzzle[ J]. Na- ture, 2002, 418:823.
  • 9Odashima M, Usui S, Takagi H, et al. Inhibition of endog- enous Mst 1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophyafter myocardial infarc- tion [J]. Circ Res, 2007, 100:1344 - 1352.

二级参考文献24

  • 1Eagle KA,Brundage BH,Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American college of cardiology /American heart association task force on practice guidelines. Circulation, 1996, 93:1278-1317.
  • 2Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American college of cardiology/ American heart association task force on practice guidelines. Circulation, 2002, 105:1257-1267.
  • 3Hlatky MA, Boineau RE, Higginbotham MB. et al. A brief self-administered questionnaire to determine functional capacity(the Duke Activity Status Index).Am J Cardiol,1989,64:651-654.
  • 4Fleisher LA,Eagle KA.Clinical practice.Lowering cardiac risk in noncardiac surgery.N Engl J Med,2001,345:1677-1682.
  • 5Hassan SA,Hlatky MA,Boothroyd DB,et al.Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the bypass angioplasty revascularization investigation(BARI).Am J Med,2001,110:260-266.
  • 6Park KW,Lee J,Breen P,et al. The risk of perioperative cardiac complications is high in major vascular surgery performed within a month of coronary artery bypass graft surgery.Anesth Analg,2002,94:S63.
  • 7Posner KL,Van Norman GA,Chan V.Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty.Anesth Analg,1999,89:553-560.
  • 8Vicenzi MN,Ribitsch D,LuhaO,et al. Coronary artery stenting before noncardiac surgery:more threat than safety?Anesthesiology,2001,94:367-368.
  • 9Park KW.Preoperative cadiology consultation.Anesthesiology,2003,98:754-762.
  • 10Grundy SM,Benjamin IJ,Burke GL,et al. Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association.Circulation,1999,100:1134-1146.

共引文献83

同被引文献43

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部